Who owns FINCH THERAPEUTICS GROUP INC?
- Ticker: FNCH
- CUSIP Number: 31773d200
Tip: Access positions for across all investors
Analyze quarterly positions in Finch Therapeutics Group with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Finch Therapeutics Group stock
Who bought or sold FINCH THERAPEUTICS GROUP INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Susquehanna International | 59k | $155k | 0% | Mar 2024 |
|
| Vanguard Group | 36k | $94k | -6% | Mar 2024 |
|
| Ikarian Capital | 6.9k | $18k | 0% | Mar 2024 |
|
| Tower Research Capital | 4.2k | $11k | 848% | Mar 2024 |
|
| Bleichroeder | 971.00 | $3.5k | 0% | Dec 2023 |
|
| BlackRock | 327.00 | $849.807600 | -4% | Mar 2024 |
|
| Morgan Stanley | 156.00 | $406.005600 | 27% | Mar 2024 |
|
| UBS Group | 110.00 | $282.854000 | 5400% | Mar 2024 |
|
| Royal Bank of Canada | 27.00 | $0 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 7.00 | $17.999800 | 17% | Mar 2024 |
|
Who sold out of Finch Therapeutics Group?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bank of America Corporation | Dec 2023 | 12.00 | $42.999600 |